• EN/ES

    Orthopedics

    WebHealthNetwork : 2,378,479


  • Benefits & Savings

  • : Leishmaniasis

Leishmaniasis - 70 Studies Found

Not yet recruiting : Single Dose Liposomal Amphotericin B for Visceral Leishmaniasis
: Visceral Leishmaniasis
: 2012-03-27
: Drug: AMBISOME SINGLE DOSE AMBISOME FOR TREATMENT OF VISCERAL LEISHMANIASIS
Terminated : Efficacy and Safety Study of Drugs for Treatment of Visceral Leishmaniasis in Brazil
: Visceral Leishmaniasis
: 2011-03-07
:
  • Drug: Antimoniate of N-methylglucamine

Terminated : Safety and Efficacy of Azithromycin to Treat Cutaneous Leishmaniasis
: Cutaneous Leishmaniasis
: 2008-05-20
:
  • Drug: Glucantime® 15mg Sb

Completed : Miltefosine to Treat Cutaneous Leishmaniasis in Bolivia
: Cutaneous Leishmaniasis
: 2005-09-28
:
  • Drug: miltefosine
  • Drug: antimony

Completed : Treatment of Leishmaniasis With Impavido® (Miltefosine): Higher-Weight Patient Registry
: Leishmaniasis
: 2015-04-22
: Drug: Miltefosine miltefosine: target 2.5 mg/kg/day for 28 days
Available : Paromomycin for Individuals With Uncomplicated Cutaneous Leishmaniasis
: Leishmaniasis, Cutaneous
: 2012-06-18
: Drug: Paromomycin Paromomycin Topical Cream applied to all lesions once a day for 20 days
Completed : Study to Evaluate the Leish-111F + MPL-SE Vaccine in the Treatment of Cutaneous Leishmaniasis
: Leishmaniasis, Cutaneous
: 2005-05-23
: Biological: Leish-111f + MPL-SE vaccine
Terminated : Safety, Efficacy, and PK of Topical Paromomycin/Gentamicin Cream for Treatment of Cutaneous Leishmaniasis
: Leishmaniasis, Cutaneous
: 2010-06-07
: Drug: WR 279,396 Topical application of WR 279,396 cream (15% paromomycin + 0.5% gentamicin)once daily f
Completed : Safety, Efficacy and Pharmacokinetics (PK) Study of WR 279,396 Versus Paromomycin for Treatment of Cutaneous Leishmaniasis (Peru-PK)
: Leishmaniasis, Cutaneous
: 2009-12-14
:
  • Drug: WR 279,396 (15% paromomycin + 0.5% gentamicin topical cream)

Completed : Pharmacokinetics, Safety, and Efficacy Trial of WR 279,396 (Paromomycin + Gentamicin Topical Cream) and Paromomycin Topical Cream for the Treatment of Cutaneous Leishmaniasis in Panama
: Leishmaniasis, Cutaneous
: 2010-03-08
:
  • Drug: WR 279,396 (15% paromomycin + 0.5% gentamicin topical cream)

<<< Previous | Next >>>
Orthopedics Health
Orthopedics Health WebHealth Network Media
  • WebHealthNetwork
  • DiabetesHealthMatters
  • HeartandStrokeHealth
  • WomensHealthCareCommunity
  • AsthmaHealthCenter
  • CancerHealthCenter
  • MentalHealthHelpCenter
  • Skincarehealthcenter
  • DigestiveTractHealth
  • VaccineHealthCenter
  • PainHealthCenter
  • FightingAddictionCenter
  • ObesityHealthMatters
  • SeniorHealthcareMatters
  • BrainAndNerveCenter
  • PediatricsHealthCenter
  • RareDiseasesHealthCenter
  • Wealth Mason
  • Home Owners Circle
  • EasyInsuranceFinder
  • EduJumpStart
  • SaleSpider
  • ScoopCafe
  • SaleSpiderMedia
  • Viewpoint.World
  • TravelerBooked
  • TechNewsBytes
  • Contact Us
  • Advertising Privacy Policy

This site uses cookies for analytics and advertising. No personal information is collected.

© Orthopedics Health .

We use cookies to enhance your experience, analyze anonymized traffic, and deliver personalized content and ads. No personal information is collected. By using our website, you consent to our use of cookies and agree to our data practices as described in our Privacy Policy. To Reject, please change your browser settings.